Clinical Trial Update: Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of retreatment with clevudine in chronic hepatitis B patients who previously received clevudine in L-FMAU-201 has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Clevudine (clevudine)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Hepatitis B | Phase 2 | Status: TERMINATED